top of page

Domestic:

+91 92 5656 7676 

International:

+1 647 893 7323 

MetGlizer™-VG 2/0.2

Glimepiride, Metformin Hydrochloride (SR) & Voglibose Tablets.

PACKING SIZE / TYPE

10x10 Tablets Blister

Summary

MetGlizer™-VG 2/0.2 is an oral antidiabetic combination therapy designed to manage Type 2 Diabetes Mellitus. It combines the insulin-sensitizing action of Metformin with the insulin-secretagogue effect of Glimepiride, providing dual glycemic control by reducing hepatic glucose production and enhancing insulin secretion.

Side Effects

Common:

  • Hypoglycemia

  • Nausea, vomiting, diarrhea, abdominal discomfort

  • Headache, dizziness

  • Weight gain (due to glimepiride)

Rare but Serious:

  • Lactic acidosis (metformin-related)

  • Allergic skin reactions

  • Hepatic dysfunction

Usage

  • To be used in patients with Type 2 Diabetes Mellitus not adequately controlled by diet, exercise, or monotherapy.

  • Taken orally with meals to reduce gastrointestinal side effects and hypoglycemia risk.

Concerns

  • May cause hypoglycemia, especially in elderly or patients with irregular meal patterns.

  • Risk of gastrointestinal disturbances due to metformin.

  • Long-term metformin use may reduce Vitamin B12 absorption.

When not to use?

Avoid in patients with:

  • Type 1 Diabetes Mellitus or Diabetic Ketoacidosis

  • Severe renal impairment (eGFR < 30 mL/min/1.73 m²)

  • Hepatic impairment

  • Hypersensitivity to Metformin or Glimepiride

  • Pregnancy and lactation (unless prescribed by a physician)

  • History of lactic acidosis

Warnings

  • Risk of lactic acidosis with metformin, especially in renal impairment.

  • Hypoglycemia risk with glimepiride, particularly with missed meals, alcohol intake, or strenuous exercise.

  • Monitor liver and kidney function regularly.

  • Use with caution in elderly, debilitated, or malnourished patients.

Dosage

  • As directed by the physician.

  • Usual starting dose: Once daily with meals, adjusted based on blood glucose response.

  • Do not crush or chew – swallow whole with water.

Interactions

  • Increased hypoglycemia risk: Sulfonylureas, insulin, beta-blockers, alcohol.

  • Reduced efficacy: Thiazide diuretics, corticosteroids, thyroid hormones, estrogens.

  • Metformin interaction: Contraindicated with iodinated contrast media (risk of lactic acidosis).

  • Monitor carefully with ACE inhibitors, NSAIDs, and certain antibiotics.

General Instructions

✅ Take with food to minimize GI effects.
✅ Follow prescribed diet and exercise plan.
✅ Regularly monitor blood glucose and HbA1c.
✅ Do not skip meals to avoid hypoglycemia.
✅ Avoid alcohol as it increases lactic acidosis & hypoglycemia risk.
✅ Inform doctor before surgery or contrast imaging.

Other Details

  • Storage: Store in a cool, dry place below 25°C, protected from moisture and sunlight.

  • Presentation: Blister/Alu-Alu strips of tablets.

  • Schedule: Schedule H Prescription Drug – To be sold only on prescription of a Registered Medical Practitioner.

References

  • American Diabetes Association. Standards of Medical Care in Diabetes—2025.

  • International Diabetes Federation (IDF) Guidelines.

  • Goodman & Gilman’s: The Pharmacological Basis of Therapeutics.

  • Brunton LL, Chabner BA, Knollmann BC. Goodman & Gilman’s Pharmacotherapy of Diabetes Mellitus.

bottom of page